Skip to main content
FEMY logo

FEMY · Femasys Inc · Metrics

Track FEMY — free
$1.12 -0.16 (-12.50%) At close · Nov 17
Market Cap
$9.70M
Shares
8.66M
Volume · Nov 17 110.56K Avg daily vol (3M) 695.5K

FEMY metrics

68 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.12
Market cap
$9.70M

Price action

23 metrics
Price change (1W)
-21.7%
Price change (30D)
-31.3%
Price change (3M)
-49.1%
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
$20.20
52-week low
$1.12
Change from 52-week high
-94.5%
Change from 52-week low
+0.0%
Annualized volatility
103.4%
Annualized volatility (3M)
98.1%
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
1.8
RSI (14D)
29.3
Price vs SMA 50
-40.8%
Price vs SMA 200
—
Avg volume (3M)
695,502
Relative volume
0.2
Average dollar volume
$1.83M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
8.66M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
4.9×
reciprocal yield 20.4%
P / book
0.4
reciprocal yield 278.8%
FCF yield
-178.7%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-125.2%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2024-03-21

Profitability

9 metrics
Gross margin
59.9%
Operating margin
-929.9%
Trailing 12 months
Net margin
-614.7%
Gross profit (TTM)
$1.18M
Operating profit (TTM)
−$18.36M
Net income (TTM)
−$12.14M
Trailing 12 months
Diluted EPS (TTM)
$-1.43
FCF margin
-877.5%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$1.97

Growth

11 metrics
Revenue growth YoY
-44.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$1.97M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+322.3%
Year over year · more shares
Revenue CAGR (3Y)
+23.9%
Revenue CAGR (5Y)
+17.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-44.9%
Return on assets
-34.6%
Debt / equity
—
Current ratio
8.7
EBITDA (TTM)
−$18.03M
Free cash flow (TTM)
−$17.33M
Quick ratio
7.0
Interest coverage
-18.9
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$23.91M
Latest balance sheet
Cash & equivalents
$23.91M
Total assets
$35.09M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$17.08M
Capital expenditures (TTM)
$245,890
R&D (TTM)
$7.01M
SG&A (TTM)
—
Stock compensation (TTM)
$619,067
R&D / revenue
355.1%
Stock compensation / revenue
31.3%

Ownership (13F)

9 metrics
13F filers
28
13F filer change QoQ
+10
Institutional ownership
75.9%
Conviction holders (share of 13F filers)
3.6%
Crowding (high-turnover and private-fund holders)
65.8%
Private-fund adviser ownership
22.5%
Active holders' share change QoQ
+229.3%
Holder tenure
4.4
Price vs estimated holder cost
-31.5%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.7%

Short interest

3 metrics
Short interest
0.6%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
33 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1339005 CUSIP 31447E204 13F (30d) 26 filings 26 filers Visit website Investor relations